本文已被:浏览 1399次 下载 1576次 |
![本文二维码信息](/download_upload_file.aspx?file_name=/uploadfile/two_dimensional_code_img/ajsmmu/2014/1/20130423.png) 码上扫一扫! |
同步诱导培养兔骨髓源性内皮祖细胞和平滑肌祖细胞 |
张永珍1,2,李文芳3,樊新生1,马小华1,吴绪敏1,张传森2* |
|
(1. 泰山学院体育学院理论教研室, 泰安 271000; 2. 第二军医大学基础部人体解剖与组织胚胎学教研室, 上海 200433; 3. 泰安市妇幼保健院儿童保健科, 泰安 271000 *通信作者) |
|
摘要: |
目的 采用兔骨髓来源的单个核细胞同步诱导分化为兔内皮祖细胞(EPCs)和平滑肌祖细胞(SPCs),研究其生物学特性,评估其作为组织工程化静脉瓣种子细胞的可能性。 方法 梯度密度离心法获取兔骨髓血单个核细胞沉淀,分别用含5%胎牛血清(FBS)的EGM-2完全培养液向EPCs方向诱导培养;用含20 ng/mL血小板源性生长因子BB、5%FBS,不含血管内皮生长因子(VEGF)的EBM-2培养液向SPCs方向诱导培养。鉴定两种细胞的分化情况。 结果 诱导的EPCs培养至10 d左右,细胞单层融合呈“铺路石”状;表达血管内皮细胞生长因子受体2(VEGFR-2)、血管性血友病因子(vWF)、CD133,不表达α-平滑肌肌动蛋白(α-SMA);透射电镜可见细胞质内特征性Weibel-Palade小体; 细胞生物学功能检测可见EPCs在基质胶上呈现血管状生长。诱导的SPCs培养至14 d左右呈现血管平滑肌细胞“峰-谷”样生长特性; 表达CD34、α-SMA,不表达vWF和VEGFR-2;在透射电镜下可见细胞内含有与细胞纵轴平行排列的肌丝; 在基质胶上不规则生长。 结论 兔骨髓血梯度密度离心得到的单个核细胞可同步诱导分化为EPCs和SPCs,为构建组织工程化静脉瓣提供了经济且可简便获取的种子细胞。 |
关键词: 内皮祖细胞 平滑肌祖细胞 组织工程化静脉瓣 组织工程 |
DOI:10.3724/SP.J.1008.2014.00068 |
投稿时间:2013-06-07修订日期:2013-07-30 |
基金项目:国家自然科学基金(30672045)。 |
|
Synchronous culture of rabbit bone narrow-derived endothelial progenitor cells and smooth muscle progenitor cells |
ZHANG Yong-zhen1,2, LI Wen-fang3, FAN Xin-sheng1, MA Xiao-hua1, WU Xu-min1, ZHANG Chuan-sen2* |
(1. Department of Theory, College of Sports, Taishan University, Taian 271000, Shandong, China; 2. Department of Human Anatomy, Histology and Embryology, College of Basic Medical Sciences, Second Military Medical University, Shanghai 200433, China; 3. Department of Child Health Care, Maternity and Child Health Hospital, Taian 271000, Shandong, China *Corresponding author.) |
Abstract: |
Objective To induce synchronous differentiation of rabbit bone marrow-derived mononuclear cells into endothelial progenitor cells (EPCs) and smooth muscle progenitor cells (SPCs), and to study their biological properties and the possibility of them as seed cells for tissue-engineered venous valves. Methods Gradient density centrifugation was used to obtain bone marrow blood mononuclear cells, which were separately cultured with EGM-2 complete medium containing 5% FBS for differentiation of EPCs and with EBM-2 medium without vascular endothelial growth factor (VEGF) containing 5% FBS and 20 ng/mL platelet-derived growth factor-BB (PDGF-BB) for differentiation of SPCs. The differentiation of EPCs and SPCs was identified by various methods. Results EPCs were cultured for 10 days and the cells fused into monolayer, showing a “stepping stone” appearance and expressing VEGF receptor-2 (VEGFR-2), von Willebrand factor (vWF) and CD133, but not α-smooth muscle actin (α-SMA); Weibel-Palade bodies were seen within the EPCs cytoplasm under the transmission electron microscope. Biological function tests showed visible EPCs growing on the matrigel in a blood vessel-like form. SPCs were cultured for 14 days and showed the specific features of the vascular smooth muscle growth, namely, the “peak-valley” growth way. SPCs expressed CD34 and α-SMA but not vWF and VEGFR-2. Myofilaments, paralleling with the cell longitudinal axis, were seen under the transmission electron microscope. SPCs could not form vessel-like structures on the matrigel. Conclusion Mononuclear cells can be obtained through gradient density centrifugation of the bone marrow blood, which can be synchronously induced into EPCs and SPCs, providing economical and easy seed cells for tissue-engineered venous valves. |
Key words: endothelial progenitor cells smooth muscle progenitor cells tissue-engineered venous valve tissue engineering |